| 000 | 01352 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512053257.0 | ||
| 264 | 0 | _c19880422 | |
| 008 | 198804s 0 0 ita d | ||
| 022 | _a0026-4725 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFazio, S | |
| 245 | 0 | 0 |
_a[Antiarrhythmic efficacy and tolerance of slow-release mexiletine in comparison with hydroquinidine retard]. _h[electronic resource] |
| 260 |
_bMinerva cardioangiologica _cNov 1987 |
||
| 300 |
_a631-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadverse effects |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xdrug therapy |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aExercise Test |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMexiletine _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aQuinidine _xadverse effects |
| 650 | 0 | 4 | _aRandom Allocation |
| 700 | 1 | _aVillari, B | |
| 700 | 1 | _aPetitto, M | |
| 700 | 1 | _aSantomauro, M | |
| 700 | 1 | _aIacono, C | |
| 700 | 1 | _aCelentano, A | |
| 700 | 1 | _ade Divitiis, O | |
| 773 | 0 |
_tMinerva cardioangiologica _gvol. 35 _gno. 11 _gp. 631-6 |
|
| 999 |
_c3450270 _d3450270 |
||